Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Transmission blocking malaria vaccines.

R Carter1

  • 1University of Edinburgh, Division of Biological Sciences, West Mains Road, EH9 3JT, Edinburgh, UK. r.carter@ed.ac.uk

Vaccine
|March 21, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Radiosensitisation of human colorectal cancer cells by ruthenium(II) arene anticancer complexes.

Scientific reports·2016
Same author

Decreased Npas4 and Arc mRNA Levels in the Hippocampus of Aged Memory-Impaired Wild-Type But Not Memory Preserved 11β-HSD1 Deficient Mice.

Journal of neuroendocrinology·2015
Same author

Chlamydia screening for pregnant women aged 16-25 years attending an antenatal service: a cost-effectiveness study.

BJOG : an international journal of obstetrics and gynaecology·2015
Same author

Maternal obesity programs offspring non-alcoholic fatty liver disease through disruption of 24-h rhythms in mice.

International journal of obesity (2005)·2015
Same author

Ovarian hyperstimulation syndrome on the acute medical unit: a problem-based review.

Acute medicine·2015
Same author

Elevated presence of myeloid dendritic cells in nasal polyps of patients with chronic rhinosinusitis.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology·2014
Same journal

Vaccination policies for healthcare personnel in Europe, 2026.

Vaccine·2026
Same journal

A historical overview of the anti-vaccine movement and its public health implications.

Vaccine·2026
Same journal

Vaccine strategies and development before and during the 1968 H3N2 influenza pandemic.

Vaccine·2026
Same journal

Influence of correlated vaccination behaviors on estimates of COVID-19 vaccine effectiveness in older adults - VISION network, October 2023 - March 2024.

Vaccine·2026
Same journal

V-safe: Summary of findings reported after COVID-19 vaccination to a US CDC active safety surveillance system through June 2023.

Vaccine·2026
Same journal

In silico selection and in vivo evaluation of scoloptoxin SSD14, Rm-inositol monophosphatase, and Rm-neprilysin as potential anti-tick vaccines.

Vaccine·2026
See all related articles

Transmission blocking vaccines (TBVs) prevent malaria transmission by targeting mosquito-infecting parasite stages. These vaccines offer community protection by reducing parasite spread from vaccinated individuals.

Area of Science:

  • Malariology
  • Vaccinology
  • Parasitology

Background:

  • Malaria remains a significant global health burden, primarily transmitted through mosquito vectors.
  • Current malaria control strategies require complementary approaches to interrupt transmission.
  • Transmission blocking vaccines (TBVs) aim to prevent malaria parasite development within mosquitoes.

Purpose of the Study:

  • To develop and evaluate transmission blocking vaccines (TBVs) for the two major human malaria species, Plasmodium falciparum and Plasmodium vivax.
  • To assess the potential of TBVs to reduce malaria transmission within communities.

Main Methods:

  • Development of candidate TBV constructs targeting parasite stages infectious to mosquitoes.
  • Pre-clinical testing of TBV candidates in animal models.

Related Experiment Videos

  • Clinical trials with human-grade TBV material are underway.

    • Main Results:

    • Candidate TBV constructs have demonstrated efficacy in animal models.
    • Testing in human clinical trials is progressing.

    Conclusions:

    • TBVs hold promise as a novel tool to combat malaria by interrupting disease transmission.
    • Community-wide vaccination with TBVs could provide localized protection, reducing overall malaria incidence.